Reply to Valenza and Cattaneo: SIRT2-mediated neuroprotection and cholesterol dyshomeostasis in Huntington’s disease

Eitemau Tebyg

• Neuroprotection and brain cholesterol biosynthesis in Huntington’s disease
  gan: Valenza, Marta, et al.
  Cyhoeddwyd: (2010)
• Erratum: Valenza et al., “Dysfunction of the Cholesterol Biosynthetic Pathway in Huntington's Disease”
  Cyhoeddwyd: (2020)
• SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis
  gan: Luthi-Carter, Ruth, et al.
  Cyhoeddwyd: (2010)
• Neuroprotective role of SIRT1 in mammalian models of Huntington’s disease through activation of multiple SIRT1 targets
  gan: Jiang, Mali, et al.
  Cyhoeddwyd: (2011)
• Decreased Striatal RGS2 Expression Is Neuroprotective in Huntington's Disease (HD) and Exemplifies a Compensatory Aspect of HD-Induced Gene Regulation
  gan: Seredenina, Tamara, et al.
  Cyhoeddwyd: (2011)